RXCELERATE LIMITED

Active Cambridge

Research and experimental development on biotechnology

97 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
R

RXCELERATE LIMITED

Research and experimental development on biotechnology

Founded 7 Nov 2012 Active Cambridge, England 97 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

TCP BIOTECH LIMITED 7 Nov 2012 — 5 Feb 2013
Accounts Submitted 14 Aug 2025 Next due 31 Aug 2026 4 months remaining
Confirmation Submitted 15 Nov 2025 Next due 21 Nov 2026 7 months remaining
Net assets £3M £2M 2024 year on year
Total assets £10M £3M 2024 year on year
Total Liabilities £7M £1M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

The Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3FH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RXCELERATE LIMITED (08284658), an active life sciences and medical technology company based in Cambridge, England. Incorporated 7 Nov 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2018–2024)

Cash in Bank

£684.00k

Decreased by £2.39M (-78%)

Net Assets

£2.60M

Decreased by £1.94M (-43%)

Total Liabilities

£7.23M

Decreased by £1.47M (-17%)

Turnover

£11.57M

Decreased by £2.38M (-17%)

Employees

97

Increased by 10 (+11%)

Debt Ratio

74%

Increased by 8 (+12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2015Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 34,753 Shares £1.86m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jan 20241£0.01£0.01
30 Jan 2024750£1.86m£2k
30 Jan 20241£0.01£0.01
28 Aug 201834,000£340£0.01
1 May 20141£0.01£0.01

Officers

Officers

2 active 1 resigned
Status
David John GraingerDirectorBritishEngland597 Nov 2012Active
Jill RecklessDirectorBritishEngland5920 Mar 2013Active

Shareholders

Shareholders (6)

Jill Reckless
37.2%
50,179
Total Medical Ventures I Llp
37.2%
50,179

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Jill Reckless

British

Active
Notified 6 Apr 2016
Residence England
DOB September 1966
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Elements Squared Limited

Ceased 24 Sept 2019

Ceased

Group Structure

Group Structure

RXCELERATE LIMITED Current Company
PROSARIX UK LTD united kingdom
RXCHEMISTRY LIMITED united kingdom
RXBIOLOGICS LIMITED united kingdom

Charges

Charges

1 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Parking Space, Parking Groves, Granta Park, Great Abington, Cambridge SOUTH CAMBRIDGESHIRE
Leasehold-19 Apr 2021
Parking Space, Parking Groves, Granta Park, Great Abington, Cambridge
Leasehold
Added 19 Apr 2021
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
18 Nov 2025ResolutionResolutions
15 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-07 with no updates
14 Aug 2025AccountsAnnual accounts made up to 2024-11-30
28 Mar 2025Persons With Significant ControlCessation of Elements Squared Limited as a person with significant control on 2019-09-24
28 Mar 2025Persons With Significant ControlChange to Total Medical Ventures I Llp as a person with significant control on 2019-09-24
18 Nov 2025 Resolution

Resolutions

15 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-07 with no updates

14 Aug 2025 Accounts

Annual accounts made up to 2024-11-30

28 Mar 2025 Persons With Significant Control

Cessation of Elements Squared Limited as a person with significant control on 2019-09-24

28 Mar 2025 Persons With Significant Control

Change to Total Medical Ventures I Llp as a person with significant control on 2019-09-24

Recent Activity

Latest Activity

Resolutions

5 months ago on 18 Nov 2025

Confirmation statement made on 2025-11-07 with no updates

5 months ago on 15 Nov 2025

Annual accounts made up to 2024-11-30

8 months ago on 14 Aug 2025

Cessation of Elements Squared Limited as a person with significant control on 2019-09-24

1 years ago on 28 Mar 2025

Change to Total Medical Ventures I Llp as a person with significant control on 2019-09-24

1 years ago on 28 Mar 2025